April 19-20,2018Day one morning-Global Industry trends
Day one afternoon to Day two
Stream A -Drug Substance
Stream B --Formulation Design and development
Stream C-- Analytical Development and Support
Stream D-- Regulatory Planning and BE Studies Session
Protech Pharmaservices Corporation (PPC)was founded in 1997 in Taipei, Taiwan to meet the growing demands for R&Doutsourcing from the Pharmaceutical and Biotech industries in the Asia-Pacificregion. Working with its worldwide customers as a leading regional ContractResearch Organization (CRO), PPC group provides professional services in“Clinical Research” (Phases I to IV) and “Contract Laboratories” (Central andBio-analytical Labs).
NeoTrident is a leading provider of scientific innovation lifecycle management software, and supports both the life science and materials science industries and organizations.
As an industry-leading information
technology company, NeoTrident portfolio is focused on integrating the
diversity of science, experimental processes, and information requirements
across research, development, QA/QC, and manufacturing. Capabilities cover
scientific data management; biological, chemical, and materials modeling and
simulation; open collaborative discovery; scientific pipelining; enterprise
laboratory management; enterprise quality management; operations intelligence
and business intelligence. We have a proven track record of enhancing
customer’s management efficiency, decision making, and innovation capabilities
through our integrated solutions. And we are willing to provide the best
practice informatic solutions and services for enterprises and research
institutions in China.
Shenzhen E-Zheng Technology Co., Ltd is a high-tech enterprise integrating technologydevelopment, equipment sales and after-sales service. E-Zheng Technology is mainly to provide customers with continuous flowprocess solution and laboratory system solution. E-Zheng Technology is a professional distributor and technical serviceprovider for continuous synthesis equipment and analytical instruments withcomplete and professional technology and personnel configuration.
In China, E-Zheng Technology is exclusive distributorand technical services provider for Chemtrix B.V. company (Micro Reactor), AM Technology (continuous stirring multistagereactor, catalytic hydrogenation system), the NiTech company (continuouscrystallization, continuous synthesizer) and AWL (continuous filtration anddrying apparatus). E-Zheng Technology can provid continuous synthesis,extraction, online continuous crystallization, online filtrationdrying, online analysis forming a acomplete continuous process solution. E-Zheng Technology established joint laboratory for micro reactorcontinuous flow technology with Zhejiang University of Technology (College ofPharmacy), Hebei University of Technology (colleage of chemical engineering)and Fudan University (chemistry department). Joint Laboratories are committed to promoting the continuous flow process inorganic synthesis, fine chemical, pharmaceutical, energy and material food andbeverage industry. JointLaboratories can also provide services to develop new flow process and help customerschange the traditional batch process into flow process promoting the pharmaceutical and fine chemicalindustries turning from traditional batch process into green, safe, fast,economic continuous flow process.
Founded in 2004, Sundia MediTech CompanyLtd. is a leading China-based CRO providing a broad range of high-quality, costeffective drug discovery and development services. Capitalizing on its broad service offerings,experienced scientists and advanced research facilities and equipment, Sundiahelps its customers discover and develop novel drug candidates efficiently. Sundia currently provides services to over160 customers globally, including a vast majority of the top 20 pharmaceuticaland biotechnology companies in the world, as well as fast-growing biotechnologyand specialty pharmaceutical companies and renowned academic and researchinstitutions. Sundia currently boasts anexperienced and strong R&D tem, comprised of over 700 employees, of over70% have post-graduate degrees and an average of 15 years of relevant industryexperience. The Company conducts itslaboratory and development activities in three primary facilities in China: a)Shanghai Zhangjiang Hi-Tech Park; b) Shijiazhuang; and c) Taicang.
Shanghai Bocimed Pharmaceutical Co., Ltd., located in Shanghai Zhangjiang High-Tech Park, is a high-tech enterprise certificated by Shanghai government. In the R&D team with more than 100 members, 40% have Ph.D. or Master Degree. The R&D center of the company is more than 2500m2, and the investment for the facilities is above 20 million RMB. Bocimed is among the earliest which has got the ISO9001:2015 certification.
The company is engaged in the whole process of drug development including R&D of high-end generic drugs, quality consistency evaluation for generic drugs, clinical research and registration service, and provides pharmaceutical companies as well as the company itself with highly-competitive new drugs.
In the 10 years after the company was founded, Bocimed has established cooperation with about 100 local and foreign pharmaceutical companies and has got good reputation. Bocimed is also listed in Top 50 pharmaceutical R&D enterprises in China.
DKSH provides market entries into Asia, Europe and the Americas through a wide range of partnerships for: Medium-sized enterprises with innovative, high-quality products. DKSH China is an international trading and marketing group with it’s headquarter in Zurich, Switzerland. Since 1990, DKSH has established trade, co-operation and friendship with China. Our products have been widely using in petroleum, petrochemical, pharmaceutical, powder, food industries etc. in
With its many sales representative offices and service centers in all over the China, DKSH provides professional analytical instruments, includes:
Particle Size Analyzer Instrument /photo optical particle analyzer－MICROTRAC
Autopol® Polarimeter, Density meter, Refractometer, Saccharimeters －RUDOLPH Research Analytical
HPTLC Densitometer －Biostep
Water Activity (a.w.) －novasina
Hotline: 4008 210 778
ViaClinical Ltd is a clinical CRO specializing in bioequivalence studies and provides services to pharmaceutical companies and R&D institutions to conduct Assessment for Quality and Interchangeability between generic and brand drug products. We havesuccessful experiences in the WHO program for Prequalification of Medicines, as well as CFDA submissions. We work with GCP and GLP compliant clinical sites in China and India.
Shandong Bestcomm Pharmaceutical Co., Ltd. ( Bestcomm Pharmaceutical，NEEQ: 836534) was established in August 2000, which is the leading domestic R&D platform company. It is the first enterprise of its kind in China obtained the certificates of conformity of Quality Management System Certification (ISO 9001:2008) and Intellectual Property Management System certification (GB/T 29490-2013), it has also won a number of honorary certificates such as the "National Technology Transfer Demonstration Institution", "First Top Ten Technology Transfer Institutions in Shandong Province", “Jinan Enterprise Technology Center”.
The company currently is staffed with more than 260 R&D employees and equipped with more than 100 high-performance liquid chromatography systems. Over 330 new pharmaceutical products have been successfully developed and over 210 products have been granted “New Drug Certificate” or “Drug Registration Approval”, additionally over 60 patents and trademarks have been granted. Now, it has established long-term stable cooperative relationships with more than 200 pharmaceutical enterprises including more than 40 of Top 100 enterprises of Chinese Pharmaceutical Industry and more than 50 listed companies.
We will continue to be guided by the "Integrity, Innovation, Cooperation and Win-Win" principle to create more value for our customers, and carry out the noble mission of “Defense of people’s health” with the outstanding enterprises together.
DXC Technology is the world’s leading business transformation company, helping clients harness the power of innovation to thrive on change. Born of the merger of CSC and the Enterprise Services business of Hewlett Packard Enterprise, DXC serves nearly 6,000 private and public-sector enterprises across 70 countries. DXC’s technology independence, global talent, expertise, and extensive alliance of partners combine to deliver the most powerful end-to-end next-generation IT services and solutions.
We are an experienced hand who has met the challenges of innovation many times before, and has a clear and confident vision for navigating the future.
We work with you, at your side, to solve complex challenges in ways that minimize business risk and maximize opportunity.
We operate differently: Our world-class talent becomes part of your team, innovating with you and putting the right technology to work for your organization. We bring along the industry’s best technology partners as integral members of our team. And we invest in building collaborative client relationships that flex and grow to help meet new challenges with confidence, speed and agility.